Molbio Diagnosti
₹1,574.4+145.10 (+10.15%)as of 2026-10-16
- Market Cap
- ₹18,087Cr.
- P/E Ratio
- 83.3
- P/B Ratio
- —
- EPS (TTM)
- ₹18.90
- Day Range
- ₹1,424.7 – ₹1,673.7
- Div Yield
- 0%
- ROCE
- 18%
- ROE
- 13.8%
52W Low: ₹1,01252W High: ₹1,687
Themes:🏥 Healthcare & Hospitals
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 59.0% a year over three years.
- Debt is 0.31× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Molbio_Diagnosti — Price
Interval
Style
Failed: 503
Scorecard
Market: risk-off · breadth 3767RS Rankvs all stocks, 1–99
33 ▲Trend (ADX)trend strength
1/4CAN SLIMprice & volume checks
upSupertrendprice vs trailing line
accum.Volume Flowbuying vs selling volume
Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 83.3P/E: 83.3 | P/B: N/AGrowth
GrowingSales CAGR — 3Y: 59% · 1Y: 35%Profitability
ModerateROCE: 18% | ROE: 13.8%Key Metrics
Valuation
PEG Ratio 0.75
Price / Sales 13.78x
Margins & returns
Operating Margin 19%
Net Margin 11.0%
Return on Assets 8.3%